Inhibition of Transforming Growth Factor-β (TGF-β) Signaling by Scutellaria baicalensis and Fritillaria cirrhosa Extracts in Endometrial Cancer

Journal of Cellular Biochemistry

Volumn 116, Issue 8, 2015, Pages 1797-1805

  Bokhari, Amber A ^a   Syed, Viqar ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

EMT; invasion; metastasis; natural products; proliferation

Indexed keywords

ANTINEOPLASTIC AGENT; FOCAL ADHESION KINASE; FOCAL ADHESION KINASE 1; FRITILLARIA CIRRHOSA EXTRACT; METALLOPROTEINASE; PLANT EXTRACT; SCUTELLARIA BAICALENSIS EXTRACT; SMAD PROTEIN; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR; CONDITIONED MEDIUM; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CANCER CELL; CANCER GROWTH; CARCINOGENIC ACTIVITY; CELL INVASION; CELL PROLIFERATION ASSAY; DOWN REGULATION; ENDOMETRIAL CANCER CELL LINE; ENDOMETRIUM CANCER; FEMALE; FRITILLARIA; HERB; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SCUTELLARIA BAICALENSIS; SIGNAL TRANSDUCTION; TUMOR INVASION; CELL MOTION; CELL SURVIVAL; CHEMISTRY; CONDITIONED MEDIUM; DRUG EFFECTS; ENDOMETRIUM TUMOR; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION; METABOLISM; PHARMACOLOGY; TUMOR CELL LINE;

FRITILLARIA CIRRHOSA; GASTROPODA; SCUTELLARIA BAICALENSIS;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; CULTURE MEDIA, CONDITIONED; ENDOMETRIAL NEOPLASMS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; FRITILLARIA; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PLANT EXTRACTS; SCUTELLARIA BAICALENSIS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84934939990     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.25138     Document Type: Article

References (45)

1. Batlle E, Sancho E, Francí C, Domínguez D, Mondar M, Baulida J, García De Herreros A,. 2000. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2: 84-89.
2. Bokhman JV,. 1983. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 15: 10-17.
3. Bolõs V, Peinado H, Pérez-Moreno MA, Fraga MF, Esteller M, Cano A,. 2003. The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J Cell Sci 116: 499-511.
4. Boukerche H, Su ZZ, Prevot C, Sarkar D, Fisher PB,. 2008. Mda-9/syntenin promotes metastasis in human melanoma cells by activating c-Src. Proc Natl Acad Sci USA 105: 15914-15919.
5. Castelbaum AJ, Ying L, Somkuti SG, Sun J, Ilesanmi AO, Lessey BA,. 1997. Characterization of integrin expression in a well differentiated endometrial adenocarcinoma cell line (Ishikawa). J Clin Endocrinol Metab 82: 136-142.
6. Chetty C, Rao JS, Lakka SS,. 2011. Matrix metalloproteinase pharmacogenomics in non-small-cell lung carcinoma. Pharmacogenomics 12: 535-546.
7. Cicchini C, Laudadio I, Citarella F, Corazzari M, Steindler C, Conigliaro A, Fantoni A, Amicone L, Tripodi M,. 2008. TGF beta-induced EMT requires focal adhesion kinase (FAK) signaling. Exp Cell Res 314: 143-152.
8. Cox BD, Natarajan M, Stettner MR, Gladson CL,. 2006. New concepts regarding focal adhesion kinase promotion of cell migration and proliferation. J Cell Biochem 99: 35-52.
9. Deb M, Sengupta D, Patra SK,. 2012. Integrin-epigenetics: a system with imperative impact on cancer. Cancer and Metastasis Rev 31: 221-234.
10. Desgrosellier JS, Cheresh DA,. 2010. Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer 10: 9-22.
11. Frame MC, Patel H, Serrels B, Lietha D, Eck MJ,. 2010. The FERM domain: organizing the structure and function of FAK. Nat Rev Mol Cell Biol 11: 802-814.
12. Freudlsperger C, Bian Y, Contag Wise, Coupar J, Yang J, Chen X, Van Waes Z,. 2013. TGF-β and NF-κB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers. Oncogene 32: 1549-1559.
13. Gold LI, Saxena B, Mittal KR, Marmor M, Goswami S, Nactigal L, Korc M, Demopoulos RI,. 1994. Increased expression of transforming growth factor beta isoforms and basic fibroblast growth factor in complex hyperplasia and adenocarcinoma of the endometrium: evidence for paracrine and autocrine action. Cancer Res 54: 2347-2358.
14. Hanahan D, Weinberg RA,. 2011. Hallmarks of cancer: the next generation. Cell 144: 646-674.
15. Katsuno Y, Lamouille S, Derynck R,. 2013. TGF-β signaling and epithelial-mesenchymal transition in cancer progression. Curr Opin Oncol 25: 76-84.
16. Kavandi L, Lee LR, Bokhari AA, Pirog JE, Jiang Y, Ahmad KA, Syed V,. The Chinese herbs Scutellaria baicalensis and Fritillaria cirrhosa target NFκB to inhibit proliferation of ovarian and endometrial cancer cells. Mol Carcinog. Epub ahead of print.
17. Kumagai T, Muller CI, Desmond JC, Imai Y, Heber D, Koeffler HP,. 2007. Scutellaria baicalensis, a herbal medicine: anti-proliferative and apoptotic activity against acute lymphocytic leukemia, lymphoma and myeloma cell lines. Leuk Res 31: 523-530.
18. Lee C, Zhang Q, Kozlowski J, Brendler C, Soares MB, Dash A, McClelland M, Mercola D,. 2013. Natural products and transforming growth factor-beta (TGF-β) signaling in cancer development and progression. Curr Cancer Drug Targets 13: 500-505.
19. Lessey BA, Albelda S, Buck CA, Castelbaum AJ, Yeh I, Kohler M, Berchuck A,. 1995. Distribution of integrin cell adhesion molecules in endometrial cancer. Am J Pathol 146: 717-726.
20. Li S, Hua ZC,. 2008. FAK expression regulation and therapeutic potential. Adv Cancer Res 101: 45-61.
21. Liang CH, Chiu SY, Hsu IL, Wu YY, Tsai YT, Ke JY, Pan SH, Hsu YC, Li KC, Yang PC, Chen YL, Hong TM,. 2013. α-Catulin drives metastasis by activating ILK and driving an αvβ3 integrin signaling axis. Cancer Res 73: 428-438.
22. Li-Weber M,. 2009. New therapeutic aspects of flavones: the anticancer properties of Scutellaria and its main active constituents wogonin, baicalein and baicalin. Cancer Treat Rev 35: 57-68.
23. Mamuya FA, Duncan MK,. 2012. αV integrins and TGF-β-induced EMT: a circle of regulation. J Cell Mol Med 16: 445-455.
24. Massagué J,. 2012. TGFβ signaling in context. Nat Rev Mol Cell Biol 13: 616-630.
25. Mitra SK, Hanson DA, Schlaepfer DD,. 2005. Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol 6: 56-68.
26. Mo N, Li ZQ, Li J, Cao YD,. 2012. Curcumin inhibits TGF-β1-induced MMP-9 and invasion through ERK and Smad signaling in breast cancer MDA- MB-231 cells. Asian Pac J Cancer Prev 13: 5709-5714.
27. Orlichenko LS, Radisky DC,. 2008. Matrix metalloproteinases stimulate epithelial-mesenchymal transition during tumor development. Clin Exp Metastasis 25: 593-600.
28. Park WS, Kim HJ, Lee GK, Son HS, Bae Y,. 2012. Anti-adhesive functions of CD43 expressed on colon carcinoma cells through the modulation of integrins. Exp Mol Pathol 92: 82-89.
29. Parvani JG, Galliher-Beckley AJ, Schiemann BJ, Schiemann WP,. 2013. Targeted inactivation of β1 integrin induces β3 integrin switching, which drives breast cancer metastasis by TGF-β. Mol Biol Cell 24: 3449-3459.
30. Principe DR, Doll JA, Bauer J, Jung B, Munshi HG, Bartholin L, Pasche B, Lee C, Grippo PJ,. TGF-β: duality of function between tumor prevention and carcinogenesis. J Natl Cancer Inst Epub ahead of print.
31. Qi HW, Xin LY, Xu X, Ji XX, Fan LH,. 2014. Epithelial-to-mesenchymal transition markers to predict response of Berberine in suppressing lung cancer invasion and metastasis. J Transl Med 24: 12-22.
32. Sheppard D,. 2005. Integrin-mediated activation of latent transforming growth factor beta. Cancer Metastasis Rev 24: 395-402.
33. Shirakihara T, Kawasaki T, Fukagawa A, Semba K, Sakai R, Miyazono K, Miyazawa K, Saitoh K,. 2013. Identification of integrin α3 as a molecular marker of cells undergoing epithelial-mesenchymal transition and of cancer cells with aggressive phenotypes. Cancer Sci 104: 1889-1897.
34. Sieg DJ, Hauck CR, Ilic D, Klingbeil CK, Schaefer E, Damsky CH, Schlaepfer DD,. 2000. FAK integrates growth-factor and integrin signals to promote cell migration. Nat Cell Biol 2: 249-256.
35. Siegel R, Ma J, Zou Z, Jemal A,. 2014. Cancer statistics, 2014. C.A Cancer J Clin 64: 9-29.
36. Tan W, Lu J, Huang M, Li Y, Chen M, Wu G, Gong J, Zhong Z, Xu Z, Dang Y, Guo J, Chen X, Wang Y,. 2011. Anti-cancer natural products isolated from Chinese medicinal herbs. Chin Med 6: 27.
37. Thiery JP, Acloque H, Huang RY, Nieto MA,. 2009. Epithelial-mesenchymal transitions in development and disease. Cell 139: 871-890.
38. Vandenbroucke RE, Dejonckheere E, Libert C,. 2011. A therapeutic role for matrix metalloproteinase inhibitors in lung diseases. Eur Respir J 38: 1200-1214.
39. Wang H, Zhang H, Tang L, Chen H, Wu C, Zhao M, Yang Y, Chen X, Liu G,. 2013. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis. Toxicology 303: 139-146.
40. Wang S, Penchala S, Prabhu S, Wang J, Huang Y,. 2010. Molecular basis of traditional Chinese medicine in cancer chemoprevention. Curr Drug Discov Technol 7: 67-75.
41. Wang SD, Chen BC, Kao ST, Liu CJ, Yeh CC,. 2014. Genistein inhibits tumor invasion by suppressing multiple signal transduction pathways in human hepatocellular carcinoma cells. BMC Complement Altern Med 16: 14-26.
42. Wipff PJ, Hinz B,. 2008. Integrins and the activation of latent transforming growth factor beta1-an intimate relationship. Eur J Cell Biol 87: 601-615.
43. Xu J, Lamouille S, Derynck R,. 2009. TGF-beta-induced epithelial to mesenchymal transition. Cell Res 19: 156-172.
44. Ye F, Jiang S, Volshonok H, Wu J, Zhang DY,. 2007. Molecular mechanism of antiprostate cancer activity of Scutellaria baicalensis extract. Nutr Cancer 57: 100-110.
45. Youns M, Hoheisel JD, Efferth T,. 2010. Traditional Chinese medicines (TCMs) for molecular targeted therapies of tumours. Curr Drug Discov Technol 7: 37-45.